Close

Akari Therapeutics Reports Full Year 2020 Financial Results and Highlights Recent Clinical Progress

Go back to Akari Therapeutics Reports Full Year 2020 Financial Results and Highlights Recent Clinical Progress
(NASDAQ: AKTX) Delayed: 1.21 --0 (-0%)
Previous Close $1.21    52 Week High $19.75 
Open $1.21    52 Week Low $7.63 
Day High $1.21    P/E N/A 
Day Low $1.21    EPS $0.00 
Volume 88